<SEC-DOCUMENT>0001144204-15-067000.txt : 20151119
<SEC-HEADER>0001144204-15-067000.hdr.sgml : 20151119
<ACCEPTANCE-DATETIME>20151119165039
ACCESSION NUMBER:		0001144204-15-067000
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20151113
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20151119
DATE AS OF CHANGE:		20151119

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOANALYTICAL SYSTEMS INC
		CENTRAL INDEX KEY:			0000720154
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				351345024
		STATE OF INCORPORATION:			IN
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-23357
		FILM NUMBER:		151244199

	BUSINESS ADDRESS:	
		STREET 1:		2701 KENT AVE
		CITY:			WEST LAFAYETT
		STATE:			IN
		ZIP:			47906-1382
		BUSINESS PHONE:		3174634527

	MAIL ADDRESS:	
		STREET 1:		2701 KENT AVENUE
		CITY:			WEST LAFAYETTE
		STATE:			IN
		ZIP:			47906-1382
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>v425273_8k.htm
<DESCRIPTION>8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">UNITED STATES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SECURITIES AND EXCHANGE COMMISSION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Washington, D.C. 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FORM 8-K</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CURRENT REPORT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
November 13, 2015</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">BIOANALYTICAL SYSTEMS, INC.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">(Exact name of registrant as specified in its charter)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 28%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Indiana</FONT></TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 38%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">0-23357 </FONT></TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 28%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">35-1345024</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(State or other </FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Commission File Number)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(I.R.S. Employer Identification </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">jurisdiction of </FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">No.)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">incorporation or </FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">organization)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 42%; text-align: center"><FONT STYLE="font-size: 10pt">2701 KENT AVENUE</FONT></TD>
    <TD STYLE="width: 16%">&nbsp;</TD>
    <TD STYLE="width: 42%; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">WEST LAFAYETTE, INDIANA</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">47906-1382</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Address of principal executive offices)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Zip Code)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Registrant's telephone number, including
area code: (765) 463-4527</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify">Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify">Soliciting material pursuant to Rule 14a-12 under the Exchange
Act(17CFR240.14a-12)</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify">Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act(17CFR240.14d-2(b))</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify">Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act(17CFR240.13e-4(c))</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 5.02 Departure of Directors or
Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On September 15, 2015, the Compensation
Committee of the Board of Directors of Bioanalytical Systems, Inc. (the &quot;Company&quot;) recommended, and the Board of the
Directors of the Company approved, entry into retention and severance agreements (the &quot;Agreements&quot;) with certain key
executives of the Company and its subsidiaries, including with Dr. James Bourdage, the Company&rsquo;s Vice President of Bioanalytical
Services. In accordance with such approval, the Company and Dr. Bourdage entered into his Agreement on November 13, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The term of each Agreement extends through
December 31, 2017, subject to automatic renewals for successive one-year terms unless either party thereto gives the other written
notice of their intent to terminate such Agreement at least 30 days before the end of the then current term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Agreements,
if the executive&rsquo;s employment is terminated other than for &quot;Good Cause&quot; or due to the executive&rsquo;s &quot;Disability&quot;
(each as defined in the Agreements), including within twenty-four months following a &quot;Change in Control&quot; (as defined
in the Agreements), if he or she resigns for &quot;Good Reason&quot; (as defined in the Agreements) within twenty-four months following
a Change in Control, or if the Company gives notice of its intention not to renew the relevant Agreement, then the Company shall
(a) pay such executive accrued pay and benefits earned through the date of his or her termination of employment, subject to the
terms and conditions of such benefits; and (b) pay such executive, as compensation for loss of office, six months base salary at
his or her then current salary in equal bi-weekly installments over the six-month period following the date of termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, with respect
to triggering terminations or resignations following a Change in Control, (a) all outstanding unvested Company options, restricted
stock or stock units held by the executive as of the termination that would have vested in accordance with their terms prior to
the first anniversary of the termination would immediately vest, with any such options remaining exercisable for a period of 30
days thereafter and (b) the executive would be entitled to receive, at the time when a payout with respect to any performance shares
held by the executive as of the termination would otherwise have been made, a pro-rata portion of the number of such performance
shares that would have been earned by the executive in accordance with the terms thereof had the executive remained employed on
the date required to earn such shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a condition of receiving
the payments and benefits under the Agreements, the relevant executive will be required to execute a general release of claims
against the Company. The Agreements also prohibit the executives from engaging in competitive solicitations of customers, certain
potential customers or employees of the Company during its term and for a six-month period following termination of employment.
The foregoing summary of the Agreements does not purport to be complete and is qualified in its entirety by reference to the Agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 9.01 Financial Statements and Exhibits</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><B>(d)</B></TD><TD STYLE="text-align: justify"><B>Exhibits:</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">10.1</TD><TD>Form of Bioanalytical Systems, Inc. Retention and Severance Agreement</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt; text-transform: uppercase">Bioanalytical Systems, Inc.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 47%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Date: November 19, 2015</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Jeffrey Potrzebowski</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-size: 10pt">Jeffrey Potrzebowski</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-size: 10pt">Chief Financial Officer,</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-size: 10pt">Vice President of Finance</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.8in; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[<FONT STYLE="font-size: 10pt">Exhibit
Index</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 12%; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Exhibit No.</B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 86%; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">10.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Form of Bioanalytical Systems, Inc. Retention and Severance Agreement.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>v425273_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0">&nbsp;&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 34%; border-bottom: Black 1pt solid; font-size: 10pt"><img src="tlogo.jpg"></td>
    <TD STYLE="width: 33%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; vertical-align: bottom">Key Employee Agreement</td>
    <TD STYLE="width: 33%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: right; vertical-align: bottom">9 November 2015</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">THIS KEY EMPLOYEE AGREEMENT
(&quot;<U>Agreement</U>&quot;) is made and entered into effective the 9<SUP>th</SUP> day of November, 2015 (the &quot;<U>Effective
Date</U>&quot;), by and between BIOANALYTICAL SYSTEMS, INC., a corporation organized under the laws of the State of Indiana (&quot;<U>BASi</U>&quot;
or the &quot;<U>Company</U>&quot;), and EMPLOYEE an individual residing in the State of Indiana (&quot;<U>Employee</U>&quot;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>Preliminary Statements:</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company is engaged in the business of providing contract research services and manufacturing and distributing scientific instruments
(the &quot;<U>Business</U>&quot;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company considers it essential to the best interests of its shareholders to foster continuous employment by the Company and its
subsidiaries of their key management personnel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Compensation Committee (the &quot;<U>Committee</U>&quot;) of the Board of Directors (the &quot;<U>Board</U>&quot;) of the Company
has recommended, and the Board has approved, that the Company enter into this Agreement with key executives of the Company and
its subsidiaries who are from time to time designated by the management of the Company and approved by the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">D.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Committee and the Board believe that Employee has made valuable contributions to the productivity and profitability of the Company
and consider it essential to the best interests of the Company and its shareholders that Employee be encouraged to remain with
the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">E.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Board believes it is in the best interests of the Company and its shareholders that Employee continue in employment with the Company
in the event of any proposed Change in Control (as defined below) and be in a position to provide assessment and advice to the
Board regarding any proposed Change in Control without concern that Employee might be unduly distracted by the personal uncertainties
and risks created by any proposed Change in Control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In consideration of the
premises and mutual covenants and agreements contained herein, the parties hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Term</U></B>.
The initial term of this Agreement shall begin on the Effective Date, and shall continue for a period ending on December 31, 2017;
provided, however, that beginning on January 1, 2018, and on the first day of each year thereafter, the term of this Agreement
shall automatically be extended by one year, unless either the Company or the Employee shall have provided notice to the other
at least thirty (30) days before such date that the term shall not be extended. Notwithstanding the preceding provisions of this
Section, if a Change in Control occurs during the term of this Agreement, such term shall not end before the second anniversary
of the Change in Control; provided, however, this sentence shall apply only to the first Change in Control while this Agreement
is in effect. If the Employee's Employment Terminates during the Term, the obligations contained in Section 6 shall survive the
Term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-top: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">Confidential</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 34%; border-bottom: Black 1pt solid"><img src="tlogo.jpg"></td>
    <TD STYLE="width: 33%; border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">Key Employee Agreement</td>
    <TD STYLE="width: 33%; border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom">9 November 2015</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Definitions</U></B>.
The following terms, when capitalized, shall have the meanings set out below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&quot;<U>Affiliated
Employer</U>&quot; means:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a
member of a controlled group of corporations (as defined in Internal Revenue Code Section 414(b) as modified by Treasury Regulation
Section 1.409A-1(h)(3)) of which the Company is a member; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;an
unincorporated trade or business that is under common control (as defined in Internal Revenue Code Section 414(c) as modified by
Treasury Regulation 1.409A-1(h)(3)) with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&quot;<U>Board</U>&quot;
means the Company's Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&quot;<U>Change
in Control</U>&quot; means the occurrence of any of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Approval
by shareholders of the Company of (a) any consolidation or merger of the Company in which the Company is not the continuing or
surviving corporation or pursuant to which shares of stock of the Company would be converted into cash, securities or other property,
other than a consolidation or merger of the Company in which holders of its common shares immediately prior to the consolidation
or merger have substantially the same proportionate ownership of voting common stock of the surviving corporation immediately after
the consolidation or merger as immediately before, or (b) a sale, lease, exchange or other transfer (in one transaction or a series
of related transactions) of all or substantially all the assets of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
change in the majority of members of the Board of Directors of the Company within a twenty-four (24) month period unless the election,
or nomination for election by the Company shareholders, of each new director was approved by a vote of two-thirds (2/3) of the
directors then still in office who were in office at the beginning of the twenty-four (24) month period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company combines with another company and is the surviving corporation but, immediately after the combination, the shareholders
of the Company immediately prior to the combination do not hold, directly or indirectly, more than fifty percent (50%) of the share
of voting common stock of the combined company (there being excluded from the number of shares held by such shareholders, but not
from the shares of voting common stock of the combined company, any shares received by affiliates (as defined in the rules of the
SEC) of such other company in exchange for stock of such other company).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">Notwithstanding
the preceding provisions, in no event shall the acquisition of shares of stock of the Company by an &quot;employee benefit plan&quot;
(within the meaning of Subsection 3(3) of the Employee Retirement Income Security Act of 1974) sponsored by the Company or an Affiliated
Employer be considered a Change in Control. In the case of a termination of employment described in Subsection 3(a)(ii), a Change
of Control shall be deemed to have occurred on the date of such termination of employment for the purpose of determining the Employee's
benefits under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-top: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">Confidential</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 34%; border-bottom: Black 1pt solid"><img src="tlogo.jpg"></td>
    <TD STYLE="width: 33%; border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">Key Employee Agreement</td>
    <TD STYLE="width: 33%; border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom">9 November 2015</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&quot;<U>Chief
Executive Officer</U>&quot; means the Chief Executive Officer of the Company or an Affiliated Employer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&quot;<U>Company</U>&quot;
means Bioanalytical Systems, Inc. and its successors and assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&quot;<U>Director</U>&quot;
means a member of the Company's Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&quot;<U>Disability</U>&quot;
means a disability as determined for purposes of any group disability insurance policy of the Company or an Affiliated Employer
in effect for Employee which qualifies Employee for long-term disability insurance payments in accordance with such policy. The
Committee may require subsequent proof of continued Disability, prior to the sixty-fifth (65th) birthday of Employee, at intervals
of not less than six (6) months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&quot;<U>Employer</U>&quot;
means the Company and each Affiliated Employer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&quot;<U>Exchange
Act</U>&quot; means the Securities Exchange Act of 1934, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&quot;<U>Good
Cause</U>&quot; means any of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a
conviction (or entry of a plea of nolo contendre thereof) for a felony or conviction (or entry of a plea of nolo contendre thereof)
for any crime or offense lesser than a felony involving misappropriation of the property of the Company, an Affiliated Employer
or a related entity, whether such conviction or plea occurs before or after termination of employment with the Employer;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;engaging
in conduct that has caused demonstrable and material injury to the Company or an Affiliated Employer or a related entity, monetary
or otherwise;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;failure
to follow the reasonable instructions of the Board, the Chief Executive Officer, or the Employee's immediate supervisor relating
to the Employee's employment or the performance of the Employee's duties and responsibilities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;dereliction
or other misconduct in the performance of the Employee's duties for the Company or an Affiliated Employer and the failure to cure
such situation within 30 days after receiving written notice thereof from the Board or the Chief Executive Officer;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
intentional disclosure or use of Confidential Information to a party unrelated to the Company or an Affiliated Employer other than
as determined in good faith by the Employee to be not contrary to the interests of the Company or believed by the Employee to be
required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-top: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">Confidential</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 34%; border-bottom: Black 1pt solid"><img src="tlogo.jpg"></td>
    <TD STYLE="width: 33%; border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">Key Employee Agreement</td>
    <TD STYLE="width: 33%; border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom">9 November 2015</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&quot;<U>Good
Reason</U>&quot; means, without the Employee's prior written consent:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a
material diminution in the Employee's base compensation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a
material diminution in the Employee's authority, duties, or responsibilities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a
material diminution in the authority, duties, or responsibilities of the supervisor to whom the Employee is required to report,
including a requirement that the Employee report to a corporate officer or employee instead of reporting directly to the board
of directors of the Company (or similar governing body with respect to an entity other than the Company);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a
material change in the geographic location at which the Employee must perform the services; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
other action or inaction that constitutes a material breach by the Company under the Agreement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">In all cases, in order for an event
to constitute Good Reason under this Agreement, the Employee must provide written notice to the Employer of the event of Good Reason
within forty-five (45) days of its initial existence, and the Employer will then have thirty (30) days after receipt of such written
notice to remedy the event of Good Reason.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&quot;<U>Notice
of Termination</U>&quot; means a written notice provided pursuant to Section 7 stating (i) the date on which the Employee's employment
with the Employer shall terminate, (ii) the specific termination provision in this Agreement relied upon, and (iii) the facts and
circumstances claimed to provide a basis for the termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&quot;<U>Specified
Employee</U>&quot; shall mean an individual who, at the time of his termination of employment with the Employer, is a &quot;specified
employee&quot; within the meaning of Code Section 409A(2)(B)(i) and Treasury Regulation Section 1.409A-1(i). For purposes of the
preceding sentence, the &quot;specified employee identification date&quot; shall be December 31 and the &quot;specified employee
effective date&quot; shall be April 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Events
Triggering Termination Benefits</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination
of Employment</U>. Subject to the provisions of <U>Section&nbsp;5</U>, the Company shall pay or provide to the Employee the termination
benefits specified in <U>Section 4</U>, if:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Employer terminates the Employee's employment prior to a Change in Control for any reason other than Good Cause or the Employee's
Disability; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-top: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">Confidential</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 34%; border-bottom: Black 1pt solid"><img src="tlogo.jpg"></td>
    <TD STYLE="width: 33%; border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">Key Employee Agreement</td>
    <TD STYLE="width: 33%; border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom">9 November 2015</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;there
is a Change in Control, and within the twenty-four (24) month period thereafter, either (A) the Employer terminates the Employee's
employment for any reason other than Good Cause or the Employee's Disability, or (B) the Employee voluntarily terminates his employment
with the Employer for Good Reason.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Notwithstanding the preceding provisions,
a &quot;termination of employment&quot; or any variation of such term shall mean a complete termination of the Employee's employment
with the Company and all related entities that constitutes a separation from service within the meaning of Code Section 409A(a)(2)(A)(i).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Non-Renewal
of Agreement by Company</U>. If the Company provides Employee with written notice of its intent not to renew this Agreement as
provided in <U>Section 1</U>, then Employee shall be entitled to the same severance benefits described in this Agreement as if
his/her employment was terminated by the Company under Subsection 3(a)(i).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Termination
Benefits</U></B>. Subject to the provisions of <U>Section 5</U> and the potential limitations of Subsection 4(f), if the Employee
becomes entitled to termination benefits pursuant to <U>Section 3</U>, the Company (or its designee) shall pay or provide the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Accrued
Pay and Benefits</U>. The Employer (or its designee) shall pay or provide to the Employee, at such times as they become payable,
Base Salary, vacation pay, bonuses, incentives, and other benefits earned through the date of his/her termination of employment,
subject to the terms and conditions of such benefits, as amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Severance
Pay</U>. The Company shall pay to Employee as compensation for loss of office six (6) months base salary at Employee&rsquo;s then
current salary in equal bi-weekly installments over the six (6) month period following the Termination Date (the &quot;<U>Severance
Period</U>&quot;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Impact
on Equity Awards</U>. Notwithstanding the terms of the Plan or of any award agreement related thereto, if the Employee's employment
is terminated pursuant to <U>Section 3(a)(ii)</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
outstanding unvested options to purchase shares of the Company's common stock held by the Employee on the effective date of termination
that would have vested in accordance with their terms prior to the first anniversary of the effective date of the termination of
the Executive's employment shall vest immediately following the termination of the Executive's employment on such effective date
and remain exercisable for a period of 30 days following such effective date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
outstanding unvested awards of restricted stock and all unvested restricted stock units held by the Executive on the effective
date of termination that would have vested in accordance with their terms prior to the first anniversary of the effective date
of the termination of the Executive's employment shall vest immediately following the termination of the Executive's employment
on such effective date; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-top: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">Confidential</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 34%; border-bottom: Black 1pt solid"><img src="tlogo.jpg"></td>
    <TD STYLE="width: 33%; border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">Key Employee Agreement</td>
    <TD STYLE="width: 33%; border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom">9 November 2015</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Executive shall be entitled to receive, at the time when a payout with respect to any performance shares held by the Executive
on the effective date of termination would otherwise have been made, a pro-rata portion (based on the number of days during the
applicable performance period on which the Executive was employed) of the number of such performance shares that would have been
earned by the Executive in accordance with the terms thereof (including the satisfaction of the performance conditions related
thereto based on the Company's actual performance) if the Executive had been employed on the date required to earn such shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Adjustment
for Excess Parachute Payments</U>. Notwithstanding any provision in this Agreement to the contrary, if the Company&rsquo;s independent
auditor (or any other independent auditor designated pursuant to written agreement of the Company and the Employee) (&quot;<U>Auditor</U>&quot;)
determines that any payment by or on behalf of the Company or an Affiliated Employer to or for the benefit of the Employee, whether
paid or payable pursuant to the terms of this Agreement or otherwise (&quot;<U>Payment</U>&quot;), would be an &quot;excess parachute
payment&quot; within the meaning of Section 280G(b)(1) of the Internal Revenue Code, the Company shall reduce the amounts otherwise
payable to the Employee under this Agreement by first reducing and forfeiting the payments required under Subsection 4(b) of this
Agreement until, in the opinion of such Auditor, such Payment would no longer constitute an &quot;excess parachute payment&quot;
within the meaning of Section 280G(b)(1) of the Internal Revenue Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Delay
in Payment for Specified Employees</U>. Notwithstanding any provisions in the Agreement to the contrary, to the extent that the
Employer has any stock which is publicly traded on an established securities market or otherwise (within the meaning of Code Section
409A) and if the Employee is a Specified Employee as of the effective date of his termination of employment with the Employer,
distribution of the termination benefits specified in this <U>Section 4</U> (to the extent that they are subject to and not otherwise
exempt or excepted from Code Section 409A (e.g., under the short-term deferral exception and/or the severance pay exception)) shall
not commence earlier than six months after the effective date of his termination of employment with the Employer. Payments delayed
by the preceding sentence shall be accumulated and paid on the earliest administratively feasible date permitted by such sentence.
Benefits delayed by this provision shall commence on the day after such delay.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Tax
Withholding</U>. The Company or its designee shall withhold taxes from payments made pursuant to this Section as required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-top: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">Confidential</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 34%; border-bottom: Black 1pt solid"><img src="tlogo.jpg"></td>
    <TD STYLE="width: 33%; border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">Key Employee Agreement</td>
    <TD STYLE="width: 33%; border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom">9 November 2015</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Release
of Claims</U></B>. The Employee agrees that, as a condition of receiving the payments and benefits described in <U>Section 4</U>,
which payments and benefits he/she is not otherwise entitled to receive, he/she will be required to execute a release in substantially
the form attached hereto as <U>Exhibit 1</U> (&quot;<U>Release</U>&quot;). Within three business days following a termination of
employment described in Subsection 3(a)(i), and within three business days following the receipt of the Notice of Termination by
the Employee for terminations described in Subsection 3(a)(ii), the Company shall provide the Employee with a copy of the Release.
The Employee shall have a period of at least 21 days after receiving the Release within which to consider the Release, and a period
of seven days following execution of the Release within which to revoke the Release. The Release shall not be effective or enforceable
until the seven-day revocation period expires and only if the Employee has not revoked such signed Release as of the end of such
seven-day period. The date on which this seven-day period expires and has not been revoked shall be the effective date of the Release
(&quot;<U>Release Effective Date</U>&quot;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">THE EXECUTIVE AGREES THAT
EXECUTION AND DELIVERY TO THE COMPANY OF THE RELEASE, AND THE PASSAGE OF THE SEVEN-DAY REVOCATION PERIOD IN CONNECTION THEREWITH,
SHALL BE A CONDITION TO THE RECEIPT OF ANY PAYMENT OR BENEFITS TO BE PROVIDED BY THE COMPANY UNDER THIS AGREEMENT.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Non-Solicitation</U></B>.
Employee agrees that during Employee&rsquo;s employment with the Company and for an additional period of the six months immediately
following termination of Employee&rsquo;s employment with the Company, Employee shall not directly or indirectly, as an individual
or as a director, officer, contractor, employee, consultant, partner, investor or in any other capacity with any corporation, partnership
or other person or entity, other than the Company (an &quot;<U>Other Entity</U>&quot;), (i) contact or communicate with any then
current material customer or client of the Company in the Business, or any person or entity with which the Company is then engaged
in material discussions regarding that person or entity becoming a client or customer of the Company in the Business, for the purpose
of inducing any such customer or client to move its account from the Company to another company in the Business; provided, however,
that nothing in this sentence shall prevent Employee from becoming employed by or providing consulting services to any such customer
or client of the Company in the Business, or (ii) solicit any other employee of the Company to leave their employment with the
Company for employment or a consulting or other services arrangement with an Other Entity or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The restrictions of this
<U>Section 6</U> shall not be deemed to prevent Employee from owning not more than 5% of the issued and outstanding shares of any
class of securities of an issuer engaged in the Business whose securities are listed on a national securities exchange or registered
pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended, or from owning any amount of securities of an issuer
who is not engaged in the Business whose securities are listed on a national securities exchange or registered pursuant to Section
12(g) of the Securities Exchange Act of 1934, as amended. In the event a court of competent jurisdiction determines that the foregoing
restriction is unreasonable in terms of geographic scope or otherwise then the court is hereby authorized to reduce the scope of
said restriction and enforce this <U>Section 6</U> as so reduced. If any sentence, word or provision of this <U>Section 6</U> shall
be determined to be unenforceable, the same shall be severed herefrom and the remainder shall be enforced as if the unenforceable
sentence, word or provision did not exist. Notwithstanding any provision of this Agreement to the contrary, the terms and conditions
of this <U>Section 6</U> shall survive for a period of six months following termination of Employee&rsquo;s employment with the
Company, at which time the terms and conditions of this <U>Section&nbsp;6</U> shall terminate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-top: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">Confidential</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 34%; border-bottom: Black 1pt solid"><img src="tlogo.jpg"></td>
    <TD STYLE="width: 33%; border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">Key Employee Agreement</td>
    <TD STYLE="width: 33%; border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom">9 November 2015</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Miscellaneous</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Relationship
between the Parties</U>. The relationship between the Company and Employee shall be that of an employer and an employee, and nothing
contained herein shall be construed or deemed to give Employee any interest in any of the assets of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices</U>.
Any notice required or permitted to be given under this Agreement shall be in writing and delivered personally or sent by certified
mail, addressed to the party entitled to receive said notice, at the following addresses:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse; margin-left: 0.75in">
<tr style="vertical-align: top">
    <TD STYLE="width: 30%">If to Company:</td>
    <TD STYLE="width: 70%">Bioanalytical Systems Inc.</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>2701 Kent Avenue</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>West Lafayette, IN&nbsp;&nbsp;47906</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>If to Employee:</td>
    <TD>EMPLOYEE</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>address on file with employee&rsquo;s records</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">or at such other address as may be
specified from time to time in notices given in accordance with the provisions of this <U>Section 7</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Enforceability</U>.
Both the Company and Employee stipulate and agree that if any portion, paragraph sentence, term or provision of this Agreement
shall to any extent be declared illegal, invalid or unenforceable by a duly authorized court of competent jurisdiction, then, (a)
the remainder of this Agreement or the application of such portion, paragraph, sentence, term or provision in circumstances other
than those as to which it is so declared illegal, invalid or unenforceable, shall not be affected thereby, (b) this Agreement shall
be construed in all respects as if the illegal, invalid or unenforceable matter had been omitted and each portion and provision
of this Agreement shall be valid and enforceable to the fullest extent permitted by law and (c) the illegal, invalid or unenforceable
portion, paragraph, sentence, term or provision shall be replaced by a legal, valid and enforceable provision which most closely
reflects the intention of the parties hereto as reflected herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Nonwaiver</U>.
The failure of either party hereto to insist in any one or more instances upon performance of any of the provisions of this Agreement
or to pursue its or her rights hereunder shall not be construed as a waiver of any such provisions or as the relinquishment of
any such rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Succession</U>.
This Agreement shall inure to the benefit of and be binding upon the parties hereto and upon their heirs, personal representatives,
and successor entities. This Agreement may not be assigned by either party without prior written agreement of both parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing</U>
<U>Law</U>. The laws of the State of Indiana shall govern the construction and enforceability of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-top: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">Confidential</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 34%; border-bottom: Black 1pt solid"><img src="tlogo.jpg"></td>
    <TD STYLE="width: 33%; border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">Key Employee Agreement</td>
    <TD STYLE="width: 33%; border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom">9 November 2015</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Entire
Agreement</U>. This Agreement constitutes the entire Agreement between the parties as to the subject matter contained herein and
all other agreements or understandings are hereby superseded and terminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Collective
Agreements</U>. There are no collective agreements which directly affect the terms and conditions of Employee's employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Heading</U>.
The headings of the sections are inserted for convenience only and do not affect the interpretation or construction of the sections.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: 0.5in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Remedies</U>.
Employee acknowledges and agrees that (i) the duration, scope and geographic areas applicable to the covenants set forth in <U>Section
6</U> are fair, reasonable and necessary, and do not impose a restraint greater than is necessary to protect the Company's legitimate
interest in its ongoing business, and (ii) adequate compensation has been received by Employee for such covenants. Employee further
acknowledges that a remedy at law for any breach or threatened breach of the provisions of <U>Section 6</U> of this Agreement would
be inadequate and therefore agrees that the Company shall be entitled to injunctive relief, both preliminary and permanent, in
addition to any other available rights and remedies in case of any such breach or threatened breach; provided, however, that nothing
contained herein shall be construed as prohibiting the Company from pursuing any other remedies available for any such breach or
threatened breach. Employee further acknowledges and agrees that in the event of a breach by Employee of any provision of <U>Section
6</U> of this Agreement, the Company shall be entitled, in addition to all other remedies to which the Company may be entitled
under this Agreement to recover from Employee its reasonable costs including attorney's fees if the Company is the prevailing party
in an action by the Company. This Agreement is entered into by the Company for itself and in trust for each of its affiliates with
the intention that each company will be entitled to enforce the terms of this Agreement directly against Employee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><I>Signature page follows</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-top: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">Confidential</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 34%; border-bottom: Black 1pt solid"><img src="tlogo.jpg"></td>
    <TD STYLE="width: 33%; border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">Key Employee Agreement</td>
    <TD STYLE="width: 33%; border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom">9 November 2015</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the
Company and Employee have executed, or caused to be executed, this Agreement as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td colspan="2" style="font-weight: bold"><b>&quot;COMPANY&quot;</b></td>
    <TD>&nbsp;</td>
    <TD STYLE="font-weight: bold"><b>&quot;EMPLOYEE&quot;</b></td></tr>
<tr style="vertical-align: top">
    <td colspan="2">&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td colspan="2" style="font-weight: bold"><b>BIOANALYTICAL SYSTEMS, INC.</b></td>
    <TD STYLE="font-weight: bold">&nbsp;</td>
    <TD STYLE="font-weight: bold">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td colspan="2">&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD STYLE="text-decoration: none; width: 3%">By:</td>
    <TD STYLE="width: 37%; border-bottom: Black 1pt solid">&nbsp;</td>
    <TD STYLE="width: 10%">&nbsp;</td>
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Jacqueline M. Lemke</TD>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>President &amp; CEO</TD>
    <TD>&nbsp;</td>
    <TD>Vice President, </td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-top: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">Confidential</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 50%"><IMG SRC="tlogo1.jpg" ALT=""></td>
    <TD STYLE="width: 50%; text-align: right; vertical-align: bottom">Exhibit A, General Release</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>exhibit
a</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Form
of release</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><U>general
release</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In exchange for the payments
and benefits set forth in the Agreement between Bioanalytical Systems, Inc. (the &ldquo;<U>Company</U>&rdquo;) and me dated as
of November 9, 2015 (the &ldquo;<U>Agreement</U>&rdquo;), and to be provided following the Effective Date (as defined below) of
this General Release and subject to the terms of the Agreement, and my execution (without revocation) and delivery of this General
Release:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
behalf of myself, my agents, assignees, attorneys, heirs, executors and administrators, I hereby release the Company and its predecessors,
successors and assigns, their current and former parents, affiliates, subsidiaries, divisions and joint ventures (collectively,
the &ldquo;<U>Company Group</U>&rdquo;) and all of their current and former officers, directors, employees, and agents, in their
capacity as Company Group representatives (individually and collectively, &ldquo;<U>Releasees</U>&rdquo;) from any and all controversies,
claims, demands, promises, actions, suits, grievances, proceedings, complaints, charges, liabilities, damages, debts, taxes, allowances,
and remedies of any type, including but not limited to those arising out of my employment with the Company Group (individually
and collectively, &ldquo;<U>Claims</U>&rdquo;) that I may have by reason of any matter, cause, act or omission. This release applies
to Claims that I know about and those I may not know about occurring at any time on or before the date of execution of this General
Release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.85in">&nbsp;&nbsp;&#9;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
General Release includes a release of all rights and Claims under, as amended, Title VII of the Civil Rights Act of 1964, the Age
Discrimination in Employment Act of 1967, the Rehabilitation Act of 1973, the Civil Rights Acts of 1866 and 1991, the Americans
with Disabilities Act of 1990, the Employee Retirement Income Security Act of 1974, the Equal Pay Act of 1963, the Family and Medical
Leave Act of 1993, the Older Workers Benefit Protection Act of 1990, the Occupational Safety and Health Act of 1970, the Worker
Adjustment and Retraining Notification Act of 1989 and the Sarbanes-Oxley Act of 2002, as well as any other federal, state, or
local statute, regulation, or common law regarding employment, employment discrimination, termination, retaliation, equal opportunity,
or wage and hour. I specifically understand that I am releasing Claims based on age, race, color, sex, sexual orientation or preference,
marital status, religion, national origin, citizenship, veteran status, disability, genetic information and other legally protected
categories.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.85in">&nbsp;&nbsp;&#9;(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
General Release also includes a release of any Claims for breach of contract, any tortious act or other civil wrong, attorneys&rsquo;
fees, and all compensation and benefit claims including without limitation Claims concerning salary, bonus, and any award(s), grant(s),
or purchase(s) under any equity and incentive compensation plan or program.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.85in">&nbsp;&nbsp;&#9;(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, I am waiving my right to pursue any Claims against the Company Group and Releasees under any applicable dispute resolution
procedure, including any arbitration policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 50%"><IMG SRC="tlogo1.jpg" ALT=""></td>
    <TD STYLE="width: 50%; text-align: right; vertical-align: bottom">Exhibit A, General Release</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">I acknowledge that this
General Release is intended to include, without limitation, all Claims known or unknown that I have or may have against the Company
Group and Releasees through the Effective Date of this General Release. Notwithstanding anything herein, I expressly reserve and
do not release pursuant to this General Release (and the definition of &ldquo;Claims&rdquo; will not include) (i) my rights with
respect to the enforcement of the Agreement, including but not limited to the right to receive severance compensation (as provided
in the Agreement), if any, and other payments and benefits specified in the Agreement, (ii) any rights or interest under any Company-sponsored
benefit plans in which I was a participant on the date of termination of my employment, (iii) any right to indemnification pursuant
to the Company&rsquo;s Certificate of Incorporation or By-laws as in effect on the date hereof, (iv) the protections of the Company
Group&rsquo;s directors and officers liability insurance, if any, in each case, to the same extent provided to other senior executives
of the Company, (v) any claims and rights that cannot be waived by law, including but not limited to my right to file an EEOC charge
but hereby waive my right to financial recovery as to any such charge, (vi) the vesting and exercise of any equity grant pursuant
to the terms of the applicable equity award agreement or the applicable equity incentive plan, and (vii) any rights as a stockholder
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I
acknowledge that I have had at least 21 calendar days from the date of my termination of employment with the Company (the &ldquo;<U>Termination
Date</U>&rdquo;) to consider the terms of this General Release, that I have been advised to consult with an attorney regarding
the terms of this General Release prior to executing it, that I have consulted with my attorney, that I fully understand all of
the terms and conditions of this General Release, that I understand that nothing contained herein contains a waiver of claims arising
after the date of execution of this General Release, and I am entering into this General Release knowingly, voluntarily and of
my own free will. I further understand that my failure to sign this General Release and return such signed General Release to the
Company, 2701 Kent Avenue, West Lafayette, IN 47906 by 5:00 p.m. on the 22<SUP>nd</SUP> day after the Termination Date will render
me ineligible for the payments and benefits described herein and in the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I
understand that once I sign and return this General Release to the Company, I have 7 calendar days to revoke it. I may do so by
delivering to the Company, 2701 Kent Avenue, West Lafayette, IN 47906 written notice of my revocation within the 7-day revocation
period (the &ldquo;<U>Revocation Period</U>&rdquo;). This General Release will become effective on the 8<SUP>th</SUP> day after
I sign and return it to the Company (&ldquo;<U>Effective Date</U>&rdquo;); provided that I have not revoked it during the Revocation
Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">YOU ARE HEREBY ADVISED
BY THE COMPANY TO CONSULT WITH AN ATTORNEY BEFORE SIGNING THIS GENERAL RELEASE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">I HAVE READ THIS GENERAL
RELEASE AND UNDERSTAND ALL OF ITS TERMS. I SIGN AND ENTER THIS GENERAL RELEASE KNOWINGLY AND VOLUNTARILY, WITH FULL KNOWLEDGE OF
WHAT IT MEANS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <td colspan="2">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</td>
    <TD STYLE="width: 5%">Date: </td>
    <TD STYLE="width: 45%; border-bottom: Black 1pt solid">&nbsp;</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Options: NewSection Last; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tlogo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tlogo.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ ' ![ P$1  (1 0,1 ?_$ +<   (" P$!
M      D*!P@ !08$ 0$!  (" P$!            "0<(! 8  0,"!1    4"
M! 4!!@0"!@L      0(#! 4&!Q$2$Q4 %!87""$Q(B,D& E!43(E,R9AH4)C
M)S@T1)2%1K9G=[<H>!$  0($! ,$!P0&"@,      0(#$1($!@ 3!0<A%!4Q
M(A8(05%A,D(C%S,DM'920U-S-QBAT9)C1(1E)B<X<30U_]H # ,!  (1 Q$
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M=0" F!TSEU,0&E%P6SOPYY@5US5/JBKDZM,Q4I0YRXI<WN%+L,I-*&."T%0
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>tlogo1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tlogo1.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ & !M P$1  (1 0,1 ?_$ )D   ,  P$!
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M*#P%.D9R5R"Y+\.L^6J@,\R6#),!4GL:Z0CKZN$ZQFJ_+1S*;:LW_<;WD9(
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BO$FT^UFO&O!=>IM^R85MEB;YNY^H)'5.U^I4Z@N@%A__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
